Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis

J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):408-17. doi: 10.1097/00126334-200008150-00002.

Abstract

Objective: A continual increase in intrapatient HIV-1 heterogeneity is thought to contribute to evasion of host immune response and eventual progression to AIDS. Tuberculosis (TB) is diagnosed both early and late during the course of HIV-1 disease and may increase diversity of HIV-1 quasispecies by activating the HIV-1 immune response and increasing HIV-1 replication. We examined whether HIV-1 heterogeneity is altered in HIV-1-infected individuals with TB.

Methods: Blood samples were obtained from 7 HIV-1-infected patients with active TB (HIV/TB patients) and 9 HIV-1-infected patients (HIV patients) in Kampala, Uganda (CD4 counts of 0-650 cells/microl and HIV loads of 700-750,000 RNA copies/ml). The C2-C3 region of the HIV-1 envelope gene (env) was amplified by nested polymerase chain reaction (PCR) from lysed peripheral blood mononuclear cells (PBMCs) of each patient, and then subject to sequencing, clonal-quasispecies analysis and heteroduplex tracking analysis (HTA).

Results: HTA of env DNA fragments showed increased heterogeneity in the HIV/TB individuals compared with the HIV group. Further sequence and HTA analysis on ten individual env clones for each patient showed significantly greater HIV mutation frequencies in HIV/TB patients than in HIV patients.

Conclusion: An increase in HIV-1 heterogeneity may be associated with a TB-mediated increase in HIV-1 replication. However, a diverse HIV-1 quasispecies population in HIV/TB patients as opposed to tight quasispecies clusters in HIV patients suggests a possible dissemination of lung-derived HIV-1 isolates from the TB-affected organ.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Base Sequence
  • Cohort Studies
  • Cross-Sectional Studies
  • DNA, Viral / blood
  • DNA, Viral / chemistry
  • Female
  • Genetic Variation*
  • HIV Envelope Protein gp120 / chemistry
  • HIV Envelope Protein gp120 / genetics
  • HIV Infections / complications
  • HIV Infections / epidemiology
  • HIV Infections / virology*
  • HIV-1 / classification*
  • HIV-1 / genetics
  • Heteroduplex Analysis
  • Humans
  • Male
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Phylogeny
  • Polymerase Chain Reaction
  • Sequence Alignment
  • Sequence Analysis, DNA
  • Tuberculosis, Pulmonary / complications*
  • Uganda / epidemiology

Substances

  • DNA, Viral
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments

Associated data

  • GENBANK/AF201765
  • GENBANK/AF201766
  • GENBANK/AF201767
  • GENBANK/AF201768
  • GENBANK/AF201769
  • GENBANK/AF201770
  • GENBANK/AF201771
  • GENBANK/AF201772
  • GENBANK/AF201773
  • GENBANK/AF201774
  • GENBANK/AF201775
  • GENBANK/AF201776
  • GENBANK/AF201777
  • GENBANK/AF201778
  • GENBANK/AF201779
  • GENBANK/AF201780
  • GENBANK/AF201781
  • GENBANK/AF201782
  • GENBANK/AF201783
  • GENBANK/AF201784
  • GENBANK/AF201785
  • GENBANK/AF201786
  • GENBANK/AF201787
  • GENBANK/AF201788
  • GENBANK/AF201789
  • GENBANK/AF201790
  • GENBANK/AF201791
  • GENBANK/AF201792
  • GENBANK/AF201793
  • GENBANK/AF201794
  • GENBANK/AF201795
  • GENBANK/AF201796
  • GENBANK/AF201797
  • GENBANK/AF201798
  • GENBANK/AF201799
  • GENBANK/AF201800
  • GENBANK/AF201801
  • GENBANK/AF201802
  • GENBANK/AF201803
  • GENBANK/AF201804
  • GENBANK/AF201856
  • GENBANK/AF201857
  • GENBANK/AF201858
  • GENBANK/AF201859
  • GENBANK/AF201860
  • GENBANK/AF201861
  • GENBANK/AF201862
  • GENBANK/AF201863
  • GENBANK/AF201864
  • GENBANK/AF201865
  • GENBANK/AF201866
  • GENBANK/AF201867
  • GENBANK/AF201868
  • GENBANK/AF201869
  • GENBANK/AF201870
  • GENBANK/AF201871
  • GENBANK/AF201872
  • GENBANK/AF201873